2021
DOI: 10.1016/j.xphs.2021.05.022
|View full text |Cite
|
Sign up to set email alerts
|

New Sodium Mefenamate – Nicotinamide Multicomponent Crystal Development to Modulate Solubility and Dissolution: Preparation, Structural, and Performance Study

Abstract: A cocrystal of mefenamic acid (MA) -nicotinamide (NA) has been reported to increase the solubility of MA, but it still does not exceed the solubility of sodium mefenamate (SM). Accordingly, this research dealt with a new salt cocrystal arrangement of SM − NA. Cocrystal screening was performed, followed by powder and single-crystal preparation. Solvent drop grinding and slow evaporation at cold and ambient temperatures were employed to produce the multicomponent crystal. Two new salt cocrystals were found as he… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 57 publications
(70 reference statements)
0
3
0
Order By: Relevance
“…The spectra of the AntiY 5 R-NaTC preparations showed a similar spectral pattern to that of AntiY 5 R, but the peak derived from the S=O of sulfonamide for AntiY 5 R shifted from 1358 cm −1 to 1375 cm −1 , while the peak derived from the S=O of sulfonate for NaTC shifted from 1169 cm −1 to 1163 cm −1 as the molar ratio of NaTC increased in the co-amorphous system. It was previously reported that Na + could interact with other molecules in addition to the molecule with which Na + forms the sodium salt [ 60 ]. Moreover, AntiY 5 R and NaTC are not able to form salts based on the calculated pKa values because their ∆pKa (∆pKa = pKa (base) − pKa (acid)) value is lower than 3 [ 61 ].…”
Section: Resultsmentioning
confidence: 99%
“…The spectra of the AntiY 5 R-NaTC preparations showed a similar spectral pattern to that of AntiY 5 R, but the peak derived from the S=O of sulfonamide for AntiY 5 R shifted from 1358 cm −1 to 1375 cm −1 , while the peak derived from the S=O of sulfonate for NaTC shifted from 1169 cm −1 to 1163 cm −1 as the molar ratio of NaTC increased in the co-amorphous system. It was previously reported that Na + could interact with other molecules in addition to the molecule with which Na + forms the sodium salt [ 60 ]. Moreover, AntiY 5 R and NaTC are not able to form salts based on the calculated pKa values because their ∆pKa (∆pKa = pKa (base) − pKa (acid)) value is lower than 3 [ 61 ].…”
Section: Resultsmentioning
confidence: 99%
“…One of the recent strategies applied to enhance physicochemical properties of active pharmaceutical compounds is by forming a multi-component crystal phase with an inert and safe coformer. This approach has shown successful improvement in solubility, dissolution rate, physical and chemical stability, and compressibility [6], [7], [8], [9], [10]. Multicomponent crystal phase between active pharmaceutical compounds and coformers could be formed due to non-covalent intermolecular interactions such as van der Waals bonds and hydrogen bonds [11].…”
Section: Introductionmentioning
confidence: 99%
“…Many times, undesired technical properties can hinder the market of a drug with suitable pharmacokinetics and pharmacodynamics, and the correct choice of a solid form rises as the only alternative to overcome them. Flowability, compactability, compressibility, tablet ability, and hygroscopicity are some examples of technical properties defining certain crystal forms to be marketed. Nowadays, the investigation of how drug technical characteristics can be modulated by the structure and presence of coformers in the solid state goes beyond the academy. Many patents of technically improved drug crystal forms have been deposited by great pharmaceutical companies, such as Pfizer, AstraZeneca, Novartis, Abbott, among others.…”
Section: Introductionmentioning
confidence: 99%